UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Mar

    28

    Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

    Mar

    27

    UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

    Mar

    12

    Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome

    Mar

    07

    Improving Dermatology Outcomes with Timely Diagnosis and Long-Lasting Treatment Options

    Mar

    05

    Voices on Value: Prioritizing Patients Now and Into the Future

    Mar

    04

    CareCompass: Transforming the care journey of caregivers and their loved ones with Dravet Syndrome or Lennox-Gastaut Syndrome

    Feb

    26

    Beyond the Diagnosis: Embracing the Humanity Behind Epilepsy Care

    Feb

    25

    Shining a Light on Resilience: Honoring Black History Month and Raising Awareness for Epilepsy

    Feb

    12

    Providing U.S. Policy Actions on Rare Disease

    Feb

    03

    Rare Disease Day 2025: Elevating the Lives of the Under-served and Under-represented